Pediatric Biomedical Imaging Initiative (PBII): Pediatric Nuclear Medicine Imaging Education Course

Monday, October 19, 2026, 8:15 AM - Tuesday, October 20, 2026, 3:00 PM, St. Jude Children's Research Hospital - Marlo Thomas Center, Memphis, TN

The Pediatric Biomedical Imaging Initiative (PBII) an initiative in the Department of Radiology at St. Jude Children’s Research Hospital. This Fall 2026 we are hosting the PBII Nuclear Medicine Course October 19–20, 2026, in Memphis.

This two-day hybrid course, offered both in person and online, will provide a multidisciplinary exploration of pediatric nuclear medicine and molecular imaging. Designed for radiologists, nuclear medicine physicians, oncologists, trainees, technologists, physicists, and multidisciplinary clinicians, the program will highlight emerging advances, clinical applications, and future directions in pediatric imaging and theranostics.

Educational sessions will feature expert perspectives on neuro-oncology, epilepsy imaging, pediatric oncology, neuroinflammation, molecular brain imaging, non-oncologic nuclear medicine applications, PET tracer development and translation, radionuclide therapy, advanced imaging instrumentation, and artificial intelligence in nuclear medicine. Additional topics will include PET/CT, PET/MR, SPECT, novel radiotracers, clinical trial design, translational imaging research, and evolving therapeutic applications in pediatric care.

Through multidisciplinary discussion and clinically focused case-based learning, participants will gain practical insight into state-of-the-art imaging approaches, emerging technologies, and innovative research shaping the future of pediatric nuclear medicine.

1. Explain the fundamental principles of pediatric nuclear medicine, including radiotracer biodistribution, radiation safety, and the selection of appropriate imaging protocols for common pediatric indications using SPECT/CT and PET/CT
2. Describe total-body or long–axial field-of-view PET/CT systems and their clinical applications in pediatric patients, including strategies for dose optimization
3. Discuss the principles, clinical indications, and safety considerations of radionuclide therapy in pediatric patients
4. Utilize knowledge of radiopharmaceuticals in designing clinical trials, including dosimetry, dosing schedules, and monitoring for adverse effects in radionuclide therapy

St. Jude Children's Research Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

St. Jude Children’s Research Hospital designates this Live Activity for a maximum of 8.50 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (8.50 hours), Non-Physician Attendance (8.50 hours)

Hotel Accommodations

Courtyard by Marriott Memphis Downtown

75 Jefferson Avenue, Memphis, Tennessee, 38103

Start Date: Saturday, October 17, 2026

End Date: Wednesday, October 21, 2026

Group Rate: $149

Book your group rate for St. Jude PB II

The faculty for this activity are listed below. Click to view the faculty member's financial disclosure information and bio. 

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.